Effect of recombinant human bone morphogenetic protein-2 on bisphosphonate-treated osteoblasts |
Kwon, Taek-Kyun
(Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University)
Song, Jae-Min (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) Kim, In-Ryoung (Department of Oral Anatomy and Cell Biology, School of Dentistry, Pusan National University) Park, Bong-Soo (Department of Oral Anatomy and Cell Biology, School of Dentistry, Pusan National University) Kim, Chul-Hoon (Department of Dentistry, Dong-A University Hospital) Cheong, In-Kyo (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) Shin, Sang-Hun (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) |
1 | Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-7. DOI ScienceOn |
2 | Kim HK, Kim JH, Abbas AA, Yoon TR. Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study. Clin Orthop Relat Res 2009;467:3121-8. DOI |
3 | Aubin J, Liu F, Bilezikian J, Raisz L, Rodan G. Principles of bone biology. 2nd ed. San Diego: Academic Press; 1996. |
4 | Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4:737-44. DOI ScienceOn |
5 | Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008;2:1-13. DOI ScienceOn |
6 | Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-52. DOI ScienceOn |
7 | Bostrom MP, Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res 1998;(355 Suppl):S124-31. |
8 | Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res 1999;14:1805-15. DOI ScienceOn |
9 | Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008;2:81-96. DOI ScienceOn |
10 | Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999;46:193-202. DOI ScienceOn |
11 | Linde A, Hedner E. Recombinant bone morphogenetic protein-2 enhances bone healing, guided by osteopromotive e-PTFE membranes: an experimental study in rats. Calcif Tissue Int 1995;56:549-53. DOI ScienceOn |
12 | Yamamoto M, Takahashi Y, Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003;24:4375-83. DOI ScienceOn |
13 | Toth JM, Boden SD, Burkus JK, Badura JM, Peckham SM, McKay WF. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine (Phila Pa 1976) 2009;34:539-50. DOI |
14 | Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, Crystal RG, et al. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 2006;39:61-71. DOI ScienceOn |
15 | Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 1995;10:1681-90. |
16 | Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 2001;142:3656-62. DOI |
17 | Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 1993;91:2004-11. DOI ScienceOn |
18 | Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9. DOI ScienceOn |
19 | Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41. DOI ScienceOn |
20 | Marx RE. Clinical concerns of alendronate use. J Oral Maxillofac Surg 2008;66:1322. DOI |
21 | Garcia-Moreno C, Serrano S, Nacher M, Farre M, Diez A, Marinoso ML, et al. Effect of alendronate on cultured normal human osteoblasts. Bone 1998;22:233-9. DOI ScienceOn |
22 | Koch FP, Merkel C, Ziebart T, Smeets R, Walter C, Al-Nawas B. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig 2012;16:79-86. DOI |
23 | Kubler NR, Wurzler KK, Reuther JF, Sieber E, Kirchner T, Sebald W. Effect of different factors on the bone forming properties of recombinant BMPs. Mund Kiefer Gesichtschir 2000;(4 Suppl 2):S465-9. DOI |
24 | Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, et al. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull 2009;32:1193-8. DOI ScienceOn |
25 | Idris AI, Rojas J, Greig IR, Van't Hof RJ, Ralston SH. Amino-bisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 2008;82:191-201. DOI |
26 | Suh DY, Boden SD, Louis-Ugbo J, Mayr M, Murakami H, Kim HS, et al. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Spine (Phila Pa 1976) 2002;27:353-60. DOI ScienceOn |
27 | Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 2000;27:479-86. DOI ScienceOn |
28 | Sudhoff H, Jung JY, Ebmeyer J, Faddis BT, Hildmann H, Chole RA. Zoledronic acid inhibits osteoclastogenesis in vitro and in a mouse model of inflammatory osteolysis. Ann Otol Rhinol Laryngol 2003;112:780-6. DOI |